Page 101 - Biotech Networks Virtual Speed Networking News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotech networks virtual speed networking. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotech Networks Virtual Speed Networking Today - Breaking & Trending Today

A Life-Extension Drug for Big Dogs Is Getting Closer to Reality

The FDA has yet to approve any drugs for life extension. But biotech company Loyal is now a step closer to bringing one to market for dogs. ....

United States , Danika Bannasch , Linda Rhodes , University Of California ,

Phathom Pharmaceuticals Announces Commercial Availability

VOQUEZNA, the first and only FDA-approved potassium-competitive acid blocker (PCAB), is now available at major retail pharmacies and through BlinkRx.. ....

United States , Colin Howden , Mark Fendrick , Diarrheacausedbyaninfection Clostridioidesdifficile , Neurogastroenterol Motil , Martin Gilligan , Nick Benedetto , Eric Sciorilli , Phathom Pharmaceuticals , Company Annual Report On Form , Phathom Pharmaceuticals Inc , Exchange Commission , Us Census Bureau , Drug Administration , University Of Tennessee College Medicine , Company On Linkedin , Erosive Esophagitis , Chief Commercial Officer , Professor Emeritus , Tennessee College , Erosive Acid Reflux , Erosive Acid , Human Immunodeficiency Virus , Patient Informationand , Prescribing Informationfor , Patient Information ,

Evaxion to Unveil Potentially Groundbreaking AI-Immunology™

Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cancers by targeting a. ....

United States , San Diego Convention Center , San Diego , Anders Bundg , American Society Of Hematology , American Society , Annual Meeting , Oral Presentation , Precision Vaccines , Retroviral Elements Constitute , Promising Vaccine Antigen Source , Artificial Intelligence , Emerging Technologies , Understanding Benign , San Diego Convention , Project Director , Nasdaq Evax , Evaxion Biotech , Cancer Vaccine ,

Elon Musk's Neuralink Raises More Cash Ahead of Human Trials Next Year

Elon Musk's brain implant company Neuralink raised a further $43 million, SEC filings show, as it prepares to put its chips in people for the first time. ....

Tech Insider , Elon Musk ,

21st Austria weekly - Marinomed, Vienna Insurance Group (21/11/2023)

21st Austria weekly - Marinomed Vienna Insurance Group 21/11/2023 [pic1]Marinomed: Marinomed Biotech AG recorded stable revenues of € 7.2 million in the first three quarters 2023 Q1-Q3 2022: 7.1 million due to continued demand for Carragelose virus blockers. The increase personnel costs higher R&D expenses and lower research subsidies were reflected operating result -4.4 -3.8 million. period amounted -5.6 million compared -5.8 prior-year period. For platform took necessary steps create an all-year product portfolio a expansion therapeutic area immunology with allergy blocker eye drops. market launches are already preparation 2024. Procter & Gamble also secured rights Carragelose-based spray USA. has paved way further important partnerships candidates Budesolv Tacrosolv which based on Marinosolv ....

United States , Comunidad Autonoma De Cataluna , Procter Gamble , Wolftank Adisa Holding , Vienna Insurance Group , Marinomed Biotech , Jefferies London Healthcare , Befektetesi Zrt , Austria Weekly , Besuchen Sie , Ic1 Marinomed , Q1 Q3 , R Amp D , Carragelose Based ,